Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.

Briumvi

Ublituximab

UblituximabCD20-directed Cytolytic Antibody [EPC]1 Variant

Clinical Data

Brand Name

Briumvi

Generic Name

Ublituximab

Active Ingredient

Ublituximab

Drug Classes

CD20-directed Cytolytic Antibody [EPC]

Important Notice

This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Briumvi, you must consult a qualified healthcare professional.

Available Variants (1)

Different strengths and dosage forms

Strength	Form	Route	NDC
150 mg/6mL	INJECTION, SOLUTION, CONCENTRATE	INTRAVENOUS	73150-150